Study details
Enrolling now
Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
Mayo Clinic
NCT IDNCT05739162ClinicalTrials.gov data as of Apr 2026
Target enrollment
12
Study length
about 3.4 years
Ages
22–69
Locations
1 site in MN
About this study
Researchers are testing if Endoscopic Sleeve Gastroplasty (ESG) can help obese people with ulcerative colitis lose weight. The trial will last 1229 days and involve a device-based treatment along with lifestyle changes.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Lifestyle Intervention
- 2.Use Apollo Endoscopic Suture System
Primary goalNumber of subjects with serious adverse events
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Number of subjects with serious adverse events, Percent total body weight loss
Secondary: Change gastrointestinal symptom rating scale (GSRS)
Body systems
Endocrinology, Gastroenterology